Jul 01, 2016

Adam Spivak, M.D. Receives Prestigious Award from Doris Duke Charitable Foundation

Adam Spivak M.D., VPCAT and KL2 scholar, and assistant professor in the Department of Medicine, has been selected to receive a Clinical Scientist Development Award (CSDA) from the Doris Duke Charitable Foundation. The CSDA is a three year, $450,000 grant that will provide resources for Spivak to build upon recent discoveries and launch a career as an independent physician scientist focusing on improving the management of HIV infection. ... Read More

Hidden in Plain Sight: Well-Known Drug Could Yield New Treatment for Herpes Viruses
Apr 13, 2016

Sankar Swaminathan published in National Academy of Sciences

Today, there is only one class of antiviral medicines against herpesviruses – a family of viruses that cause mononucleosis, herpes, shingles, and meningitis among other illnesses – meaning options for treating these infections are limited. If viruses become resistant to these frontline treatments, a growing problem particularly in clinical settings, there are no alternative drugs to serve as backup. Read More